Quick answer: MDPV (commonly searched as MDVP) is a Schedule I synthetic cathinone. Zaza refers to tianeptine sold in convenience stores. Neither substance is included in the HHS Mandatory Guidelines urine 5-panel. Instant immunoassay strips used in treatment give a preliminary result only. Every positive must be confirmed by GC/MS or LC-MS/MS laboratory testing.
- MDPV/MDVP and tianeptine (Zaza) are not HHS 5-panel analytes, so a standard clinic cup will not report them.
- Run an FDA-cleared, CLIA-waived multi-panel urine screen, then order expanded LC-MS/MS when MDPV or Zaza use is suspected.
- American Screening Corp supplies 5- to 18-panel cups and dip cards to clinics, courts, and treatment centers; every screen positive is preliminary.
Last updated November 2026. Reviewed for clinic, court, and treatment-center purchasing.
What are MDPV (MDVP) and Zaza?
Treatment-center buyers who search "MDVP zaza strips for treatment" are trying to detect two different drugs during intake or random screening. They are not the same analyte and they are not interchangeable with MDMA or opiates.
Need drug tests for your clinic, program or workplace?
American Screening Corp has supplied FDA-cleared, CLIA-waived tests at wholesale pricing since 2004. Popular options:
Ordering 100+ tests? Request volume pricing.
MDPV (3,4-methylenedioxypyrovalerone) is a synthetic cathinone. The Drug Enforcement Administration lists MDPV as Schedule I. NIDA groups MDPV with synthetic cathinones, sometimes called bath salts. Buyers often type the name as MDVP.
Zaza is a store-brand name used for tianeptine products. The Food and Drug Administration states tianeptine is not approved for any medical use in the United States, as of the FDA consumer update "Tianeptine Products Linked to Serious Harm, Overdoses, Death."
Opioid-treatment programs, detox units, and court-ordered counseling see both drugs. Neither drug is an HHS 5-panel analyte.
Do standard strips detect MDPV or Zaza?
A standard FDA-cleared multi-panel urine cup does not print an MDPV result or a tianeptine result. Searching for "MDVP zaza strips" does not change what the labeled pads on a 5- to 18-panel device actually detect.
The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs, as of the current urine program, cover marijuana metabolites, cocaine metabolite, codeine/morphine, hydrocodone/hydromorphone, oxycodone/oxymorphone, 6-acetylmorphine, phencyclidine, amphetamine/methamphetamine, and MDMA/MDA. MDPV and tianeptine are not on that list.
Do not read an amphetamine or MDMA pad as an MDPV test. Cross-reactivity is not an HHS method. Do not read an opiate or buprenorphine pad as a Zaza test.
If a box claims a tianeptine or synthetic-cathinone line, read the intended-use statement. Forensic-use-only devices are not CLIA-waived diagnostic tests. Every immunoassay result is preliminary. Confirm every positive by GC/MS or LC-MS/MS laboratory testing.
Cutoff levels, detection windows, FDA/CLIA status, and who kits are for
HHS urine initial test cutoffs include amphetamines at 500 ng/mL, MDMA/MDA at 500 ng/mL, cocaine metabolite at 150 ng/mL, codeine/morphine at 2,000 ng/mL, and phencyclidine at 25 ng/mL (Mandatory Guidelines for Federal Workplace Drug Testing Programs).
HHS does not publish an MDPV cutoff in ng/mL. HHS does not publish a tianeptine cutoff in ng/mL.
NIDA materials on synthetic cathinones describe short urine windows for many stimulants, often about 1 to 3 days. That figure is not a validated MDPV or tianeptine window. Lab method, dose, and hours since last use change the result.
FDA-cleared, CLIA-waived cups and dip cards in 5- to 18-panel formats are for professional buyers: clinics, treatment centers, probation and courts, employers, staffing firms, and laboratories. They do not diagnose a disorder. They do not replace laboratory confirmation.
| Drug or product | On HHS urine panel? | Screen cutoff | Urine detection window | Instant result meaning |
|---|---|---|---|---|
| MDPV (MDVP) | No | Not set by HHS | Not standardized by SAMHSA | Not reported on a 5- to 18-panel cup |
| Tianeptine (Zaza) | No | Not set by HHS | Not standardized by SAMHSA | Not reported on a 5- to 18-panel cup |
| Amphetamines | Yes | 500 ng/mL initial | Often about 1–3 days (NIDA) | Preliminary; confirm by GC/MS or LC-MS/MS |
| MDMA/MDA | Yes | 500 ng/mL initial | Often about 1–3 days (NIDA) | Preliminary; confirm by GC/MS or LC-MS/MS |
| Cocaine metabolite | Yes | 150 ng/mL initial | Often about 2–4 days (NIDA) | Preliminary; confirm by GC/MS or LC-MS/MS |
| Codeine/morphine | Yes | 2,000 ng/mL initial | Often about 1–3 days (NIDA) | Preliminary; confirm by GC/MS or LC-MS/MS |
How should a treatment program test when MDPV or Zaza is suspected?
Use this sequence on the clinic floor. It covers the panel you can screen today and the lab step these two drugs still require.
- Write down the program, court, or employer rule that requires the test.
- Collect urine with an FDA-cleared, CLIA-waived multi-panel device for the analytes that rule actually names. Professional sites use drug test cups or drug test dip cards in 5- to 18-panel configurations.
- Read the device at the insert time, commonly 5 minutes. A missing line at a labeled pad is a preliminary positive.
- Do not treat a negative amphetamine, MDMA, or opiate pad as negative for MDPV or Zaza.
- When history points to bath salts or Zaza, order LC-MS/MS or GC/MS expanded testing on that specimen.
- Record chain of custody when the result may affect treatment status or a court report. Instant screens are not confirmatory.
Cup or dip card on a treatment unit?
Cups combine collection and the test panel in one device. That reduces pour-off steps on a busy detox floor.
Dip cards require a separate collection cup, then dipping the card. They suit labs and high-volume benches that already pour specimens.
Both formats are immunoassay screens. Choose the panel count that matches written policy, not a hope that MDPV or Zaza will appear on an unlabeled pad.
Checklist before you order strips for treatment
- Confirm the written panel required by the OTP, court, or employer contract.
- Stock 5- to 18-panel FDA-cleared, CLIA-waived cups or dip cards for those analytes.
- Place a standing GC/MS or LC-MS/MS confirmation order.
- Add an expanded tianeptine and synthetic-cathinone request when Zaza or bath salts are in the history.
- Read every box for forensic-use-only versus CLIA-waived.
- Train staff that every positive screen is preliminary.
- File the package insert with the lot number in the quality record.
What treatment buyers ask
Purchasing managers ask whether Zaza will light up the opiate line and whether MDVP is another name for MDMA. It is not. Support calls also ask for one strip that covers fentanyl, ETG, MDPV, and tianeptine in a single read.
Fentanyl and ETG are separate, labeled tests. MDPV and tianeptine belong on the confirmation report unless the exact device in hand lists those lines and states FDA/CLIA status. Do not invent a pad that the insert does not name.
Frequently asked questions
Will a 12-panel cup detect MDPV or Zaza?
No. Typical 12-panel cups test drugs such as THC, cocaine, opiates, amphetamines, benzodiazepines, barbiturates, methadone, MDMA, oxycodone, and buprenorphine. MDPV and tianeptine are not those lines. Confirm with GC/MS or LC-MS/MS.
What cutoff levels apply to MDVP or Zaza strips?
HHS does not set MDPV or tianeptine cutoffs. SAMHSA urine amphetamine and MDMA screens use 500 ng/mL. Any dedicated strip cutoff is manufacturer-specific and preliminary only.
Are MDPV or Zaza strips FDA-cleared and CLIA-waived?
Do not assume they are. Verify 510(k) and CLIA-waived status on the device label. Forensic-use-only strips are not diagnostic tests. Use FDA-cleared multi-panel cups for covered drugs and confirm in the lab.
What should a treatment center do if a client uses Zaza or bath salts?
Document the report. Collect urine. Run the program's FDA-cleared panel. Order LC-MS/MS for tianeptine and synthetic cathinones. Treat immunoassay positives as preliminary. Follow program and court policy.
Sources
- Tianeptine Products Linked to Serious Harm, Overdoses, Death (FDA)
- Synthetic Cathinones (Bath Salts) (NIDA)
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (HHS/SAMHSA)
This article is general information for professional buyers and is not medical or legal advice.




